STOCK OPTIONS AND WARRANTS (Details 3) - $ / shares |
3 Months Ended | |
|---|---|---|
Mar. 31, 2024 |
Dec. 31, 2023 |
|
| Exercisable, Number of Options | 934,026 | |
| Warrants Exercisable [Member] | ||
| Exercise price | $ 3.16 | |
| Exercisable, Number of Options | 1,765,856 | |
| Weighted average remaining life in years | 2 years 6 months | |
| Warrants Outstanding [Member] | ||
| Exercise price | $ 3.16 | |
| Weighted average remaining life in years | 2 years 6 months | |
| Number of outstanding | 1,765,856 | |
| 3.31 [Member] | Warrants Exercisable [Member] | ||
| Exercise price | $ 3.16 | |
| Exercisable, Number of Options | 1,765,856 | |
| Weighted average remaining life in years | 2 years 6 months | |
| 3.31 [Member] | Warrants Outstanding [Member] | ||
| Exercise price | $ 3.16 | |
| Weighted average remaining life in years | 2 years 6 months | |
| Number of outstanding | 1,765,856 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Per share increase in exercise price of warrant. Excludes change due to standard antidilution provision. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|